| 2005 |
WNK1 and WNK4 directly phosphorylate OSR1 at two sites: Thr185 in the T-loop of the catalytic domain and Ser325 in a C-terminal non-catalytic region. Phosphorylation of Thr185 is required for OSR1 activation; T185A mutation prevents activation by WNK1, while T185E (phosphomimetic) increases basal activity >20-fold. Mutation of Ser325 does not affect activity or WNK1-mediated activation. |
In vitro kinase assay, phosphopeptide mapping, site-directed mutagenesis |
The Biochemical journal |
High |
16083423
|
| 2005 |
WNK1 phosphorylates OSR1 at an evolutionarily conserved serine residue outside the kinase domain, and mutation of this residue causes enhanced OSR1 kinase activity. SPAK and OSR1 directly phosphorylate the N-terminal regulatory regions of cation-chloride cotransporters NKCC1, NKCC2, and NCC. Phosphorylation of NCC is induced by hypotonic stress in cells. |
In vitro kinase assay, cell-based phosphorylation assays, hypotonic stress treatment |
The Journal of biological chemistry |
High |
16263722
|
| 2002 |
OSR1 physically interacts with the cation-chloride cotransporters KCC3, NKCC1, and NKCC2 (but not KCC1 or KCC4) through the last 100 amino acids of OSR1. The binding motif on cotransporters consists of nine residues starting with (R/K)FX(V/I). Co-immunoprecipitation confirmed in vivo interaction of the related kinase SPAK with NKCC1 from mouse brain. |
Yeast two-hybrid, GST pull-down, co-immunoprecipitation, immunohistochemistry |
The Journal of biological chemistry |
High |
12386165
|
| 2006 |
OSR1 exists in a complex with WNK1 in cells, is activated by recombinant WNK1 in vitro, and is phosphorylated in a WNK1-dependent manner in cells. Depletion of WNK1 by siRNA reduces OSR1 kinase activity. Depletion of either WNK1 or OSR1 reduces NKCC activity in HeLa cells, placing both in a pathway required for NKCC function and volume regulation. |
Co-immunoprecipitation, in vitro kinase assay, siRNA knockdown, NKCC activity assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16832045
|
| 2006 |
OSR1 possesses a 92-residue conserved C-terminal (CCT) domain that interacts with RFXV motifs present in both substrates (NKCC1) and activators (WNK1/WNK4). A peptide containing the RFXV motif binds the CCT domain with nanomolar affinity. Mutation of specific CCT domain residues inhibits OSR1-mediated phosphorylation of NKCC1 (which requires RFXV docking) but not of CATCHtide (which lacks RFXV). An intact CCT domain is required for WNK1 to efficiently phosphorylate and activate OSR1. |
In vitro kinase assay, peptide binding/affinity purification, CCT domain mutagenesis, CATCHtide peptide substrate development |
The Biochemical journal |
High |
16669787
|
| 2006 |
OSR1 shares similar kinase properties to SPAK and similarly activates NKCC1 when co-expressed with WNK4 in Xenopus oocytes. OSR1 kinase activity is markedly inhibited by staurosporine and K252a, partially inhibited by N-ethylmaleimide and diamide, and unaffected by arsenite. Activity is stronger with Mn2+ than Mg2+. |
Xenopus oocyte expression system, in vitro kinase assay, pharmacological inhibitor profiling |
Molecular and cellular biology |
High |
16382158
|
| 2007 |
Crystal structure of the CCT domain of OSR1 in complex with a WNK4-derived RFXV motif-containing peptide was solved, revealing a novel protein fold with a surface-exposed groove that mediates peptide binding. Phosphorylation of a Ser/Thr residue preceding the RFXV motif causes steric clash, promoting dissociation from the CCT domain. Mutational analysis confirmed that the groove interactions are required for binding to WNK1 and NKCC1. |
X-ray crystallography, mutational analysis, binding assays |
EMBO reports |
High |
17721439
|
| 2008 |
SPAK and OSR1 phosphorylate human NCC at three conserved residues (Thr46, Thr55, Thr60) in response to WNK1 pathway activation by hypotonic low-chloride conditions. Efficient NCC phosphorylation requires docking interaction between an RFXI motif in NCC and SPAK/OSR1. Mutation of Thr60 to Ala markedly inhibits phosphorylation of Thr46 and Thr55 and abolishes NCC activation by hypotonic low-chloride treatment. |
In vitro kinase assay, site-directed mutagenesis, cell-based phosphorylation assay in HEK293 and mpkDCT cells |
Journal of cell science |
High |
18270262
|
| 2004 |
OSR1 (oxidative stress-responsive 1) is a 58-kDa, 527-amino acid STE20 family kinase widely expressed in mammalian tissues. Endogenous OSR1 is activated specifically by osmotic stresses (notably sorbitol, and to a lesser extent NaCl). OSR1 does not activate JNK, p38, ERK2, or ERK5. OSR1 phosphorylates PAK1 at Thr84 in its N-terminal regulatory domain; T84E substitution reduces PAK1 activation by Cdc42, suggesting OSR1 modulates G-protein sensitivity of PAK. |
Two-hybrid screen, in vitro kinase assay, site-directed mutagenesis, osmotic stress activation assays |
The Journal of biological chemistry |
High |
14707132
|
| 2009 |
Crystal structure of the OSR1 kinase domain was solved at 2.25 Å resolution, revealing a domain-swapped dimer in an inactive conformation in which the P+1 loop and αEF helix are swapped between dimer-related monomers. Structural integrity of chemical interactions is preserved in the domain-swapped interfaces. |
X-ray crystallography (2.25 Å resolution) |
Protein science |
High |
19177573
|
| 2011 |
MO25α and MO25β bind to OSR1 (and SPAK) and induce ~100-fold activation of their kinase activity, dramatically enhancing phosphorylation of ion cotransporters NKCC1, NKCC2, and NCC. siRNA-mediated reduction of MO25 in mammalian cells inhibits phosphorylation of endogenous NKCC1 at SPAK/OSR1-dependent sites, rescued by re-expression of MO25α. MO25 associates with OSR1 in a manner analogous to its interaction with the STRAD pseudokinase. |
In vitro kinase assay, co-immunoprecipitation, siRNA knockdown, rescue experiments, surface plasmon resonance |
The EMBO journal |
High |
21423148
|
| 2011 |
In vivo genetic evidence confirms that NCC phosphorylation by the WNK4 D561A mutation is almost completely abolished in triple knock-in mice where both SPAK (T243A) and OSR1 (T185A) cannot be activated by WNK kinases. This establishes that NCC phosphorylation in vivo is dependent on the WNK-OSR1/SPAK cascade, and that PHAII caused by WNK4 D561A requires OSR1/SPAK activation. |
Genetic knock-in mouse model, immunoblotting for phospho-NCC, blood pressure and metabolic measurements |
Journal of cell science |
High |
21486947
|
| 2011 |
SPAK/OSR1 directly phosphorylate NKCC2 isoforms at Thr95, Thr100, Thr105 (and possibly Ser91) via interaction with an RFQV docking motif on NKCC2. A SPAK-OSR1-independent kinase (possibly AMPK) phosphorylates Ser130. Phosphorylation of Thr105 and Ser130 plays the most important role in stimulating NKCC2 activity. Unlike NCC, NKCC2 is constitutively membrane-localized and not regulated by SPAK/OSR1-dependent membrane translocation. |
In vitro kinase assay, cell-based phosphorylation assay, site-directed mutagenesis, NKCC2 isoform analysis |
Journal of cell science |
High |
21321328
|
| 2012 |
SPAK/OSR1 double-knockin ES cells (where both kinases cannot be activated by WNK1) show no phosphorylation or activation of NKCC1, providing genetic evidence that SPAK/OSR1 are essential for NKCC1 function. WNK1 and WNK3 activities are markedly elevated in these knockin cells, demonstrating that SPAK/OSR1 feedback to influence upstream WNK activity. Phosphorylation of WNK1 Ser1261 is unaffected, indicating it is not a SPAK/OSR1 substrate. |
Double-knockin ES cells, immunoblotting, NKCC1 activity assay, in vitro kinase assay |
The Biochemical journal |
High |
22032326
|
| 2012 |
In the kidney, OSR1 activity is dependent on SPAK in the distal convoluted tubule (DCT) but not the thick ascending limb (TAL). In SPAK-null mice, OSR1 becomes largely inactive, displaced from MO25α and NCC at the apical membrane, and redistributes to dense cytoplasmic punctate structures containing WNK1. This demonstrates that SPAK is required for proper OSR1 localization and activity in DCT, and that OSR1 apical membrane localization is functionally linked to NCC phosphorylation. |
SPAK knockout mice, immunofluorescence, subcellular fractionation, immunoblotting |
The Journal of biological chemistry |
High |
22977235
|
| 2012 |
PI3K/mTORC2 activates OSR1 by phosphorylating it on Ser339. Inhibition of PI3K reduces OSR1 activation by osmotic stress, and depletion of Sin1 (mTORC2 component) decreases OSR1 activation by sorbitol and reduces NKCC activity in HeLa cells. Mutation of Ser339 eliminates mTORC2-dependent OSR1 phosphorylation, identifying a convergent regulatory node on OSR1 from the PI3K pathway. |
In vitro kinase assay (mTORC2 phosphorylates OSR1), pharmacological inhibition, siRNA knockdown of Sin1, site-directed mutagenesis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
24191005
|
| 2012 |
OSR1 participates in regulation of renal tubular phosphate transport via NaPiIIa. Coexpression of OSR1 in Xenopus oocytes significantly upregulates phosphate-induced currents in NaPiIIa-expressing oocytes. In osr1tg/(+) mice carrying a WNK-resistant OSR1, urinary phosphate excretion is increased and NaPiIIa protein abundance in brush border membrane is reduced, associated with elevated serum FGF23. |
Xenopus oocyte electrophysiology, mouse knock-in model, immunohistochemistry, confocal microscopy |
Kidney & blood pressure research |
Medium |
23095210
|
| 2012 |
The phosphorylation levels of OSR1, SPAK, and NCC exhibit a diurnal rhythm in mouse kidney that correlates with active/rest periods. This circadian rhythm of the WNK4-OSR1/SPAK-NCC cascade is abolished by eplerenone (aldosterone receptor blocker), indicating aldosterone governs the circadian oscillation of this kinase cascade. |
Time-course immunoblotting in mice, pharmacological treatment with eplerenone |
Biochemical and biophysical research communications |
Medium |
23044422
|
| 2012 |
ASK3 (apoptosis signal-regulating kinase 3) interacts with WNK1 and suppresses the WNK1-SPAK/OSR1 signaling pathway. Knockdown of ASK3 enhances SPAK/OSR1 activation, and ASK3 knockout mice show hyperactivation of SPAK/OSR1 in renal tubules and a hypertensive phenotype, positioning ASK3 as an upstream suppressor of the WNK1-SPAK/OSR1 pathway in response to osmotic stress. |
Co-immunoprecipitation (WNK1-ASK3 interaction), siRNA knockdown, ASK3 knockout mice, immunoblotting |
Nature communications |
High |
23250415
|
| 2012 |
Estradiol treatment of newborn rat pups significantly increases protein levels of OSR1 (and SPAK) in the hypothalamus via a transcription-dependent mechanism. OSR1 knockdown by antisense oligonucleotides precludes estradiol-mediated enhancement of NKCC1 phosphorylation and diminishes estradiol-enhanced Ca2+ influx induced by GABAAR activation in embryonic hypothalamic cultures. |
In vivo neonatal rat treatment, immunoblotting, antisense knockdown, calcium imaging |
The Journal of neuroscience |
Medium |
22238094
|
| 2013 |
WNK1 activates the OSR1 signaling cascade to regulate embryonic cardiovascular development. Global or endothelial-specific deletion of Osr1 in mice causes embryonic lethality at ~E11 with identical cardiovascular defects to WNK1 knockout (no mature large vessels in yolk sacs, defective angiogenesis, smaller cardiac chambers). Endothelial-specific expression of constitutively active OSR1 rescues angiogenesis and cardiac defects in global WNK1-null embryos, establishing OSR1 as an essential downstream effector of WNK1 in vascular development. |
Conditional knockout mice (Tie2-Cre), constitutively active OSR1 transgene rescue, embryonic phenotype analysis |
The Journal of biological chemistry |
High |
23386621
|
| 2014 |
WNK-activated SPAK/OSR1 (in the presence of MO25) directly phosphorylates all KCC isoforms at Site-2 (Thr1048 in KCC3A) in vitro, promoting their inhibition. In ES cells lacking SPAK/OSR1 activity, endogenous KCC Site-2 phosphorylation is abolished and KCC3A activity is elevated. A Site-2 alanine KCC3A mutant preventing SPAK/OSR1 phosphorylation shows increased activity, confirming that SPAK/OSR1 phosphorylation inhibits KCC-mediated Cl- efflux. SPAK/OSR1 also phosphorylate KCCs at Site-3 (Thr5/Thr6) and Site-4 (Ser96). |
In vitro kinase assay with MO25, knockin ES cells lacking SPAK/OSR1 activity, 86Rb+ uptake assay, site-directed mutagenesis |
The Biochemical journal |
High |
24393035
|
| 2014 |
WNK1-OSR1 signaling is required for HUVEC cord formation, chemotaxis, and invasion. OSR1 (but not SPAK) is specifically required for HUVEC chemotaxis and invasion, while SPAK is required for proliferation. OSR1 and WNK1 regulate the zinc-finger transcription factor Slug in endothelial cells. Constitutively active OSR1 rescues WNK1 deficiency, confirming OSR1 acts downstream of WNK1 in endothelial function. |
siRNA knockdown, cord formation assay, chemotaxis/invasion assay, gene expression analysis, HUVEC culture |
Proceedings of the National Academy of Sciences of the United States of America |
High |
25362046
|
| 2014 |
OSR1 activates inward rectifier K+ channels Kir2.1 and Kir2.3 via an R-x-F-x-V/I motif variant (distinct from the canonical RFXV). Mutation of the RxFxV motif in Kir2.3 prevents its activation by OSR1. Both siRNA knockdown of OSR1 and chemical WNK inhibition disrupt NaCl-induced plasma membrane localization of Kir2.3, suggesting OSR1 enhances Kir2.1/Kir2.3 activity by increasing their plasma membrane localization. Kir4.1, which lacks this motif, is insensitive to OSR1. |
siRNA knockdown, pharmacological WNK inhibition, plasma membrane localization assay, site-directed mutagenesis of binding motif, Xenopus oocyte expression |
Proceedings of the National Academy of Sciences of the United States of America |
High |
29581290
|
| 2014 |
OSR1 directly interacts with and phosphorylates Smad2 at Thr220 and Smad3 at Thr179 in the linker region. This phosphorylation causes nuclear translocation of Smad2/3 and enhances TGF-β1 autocrine signaling, driving epithelial-to-mesenchymal transition (EMT) and metastasis in breast cancer cells. OSR1 deletion in aggressive breast cancer cells inhibits EMT, and disruption of the OSR1-Smad2/3-TGF-β1 axis reduces metastasis in vitro and in vivo. |
Co-immunoprecipitation, in vitro kinase assay, site-directed mutagenesis, nuclear translocation assay, loss-of-function (CRISPR/deletion), in vivo metastasis models |
Oncogene |
High |
33051597
|
| 2014 |
OSR1 negatively regulates the creatine transporter SLC6A8 in Xenopus oocytes. Constitutively active (T185E)OSR1 reduces creatine transport, but catalytically inactive (D164A)OSR1 does not, indicating the effect requires OSR1 kinase activity. WNK-insensitive (T185A)OSR1 still negatively regulates SLC6A8, suggesting a WNK-independent mechanism for this substrate. |
Xenopus oocyte expression system, dual electrode voltage clamp, constitutively active and catalytically inactive OSR1 mutants |
Kidney & blood pressure research |
Medium |
25531585
|
| 2014 |
Active OSR1 (T185E) downregulates ROMK1 K+ channel protein abundance at the cell membrane and channel activity in Xenopus oocytes; catalytically inactive (D164A)OSR1 has no effect. This is consistent with OSR1 kinase activity-dependent regulation of ROMK1 membrane trafficking. |
Xenopus oocyte expression, dual electrode voltage clamp, chemiluminescence-based surface protein assay |
Kidney & blood pressure research |
Medium |
25322850
|
| 2014 |
Active OSR1 (T185E) negatively regulates ClC-2 Cl- channel activity in Xenopus oocytes. WNK1-insensitive inactive (T185A)OSR1 and catalytically inactive (D164A)OSR1 have no effect. Brefeldin A experiments suggest OSR1 does not accelerate ClC-2 retrieval from the membrane, indicating a different regulatory mechanism. |
Xenopus oocyte expression, dual electrode voltage clamp, brefeldin A treatment |
Kidney & blood pressure research |
Medium |
25323061
|
| 2014 |
WNK1-OSR1 signaling promotes glioma cell migration. siRNA knockdown of WNK1 or OSR1 reduces intracellular K+ and Cl- content and abolishes NKCC1 regulatory phospho-activation, impeding regulatory volume increase in glioma cells. Temozolomide activates the WNK1/OSR1/NKCC1 pathway and enhances glioma migration, which is blocked by OSR1 siRNA knockdown. |
siRNA knockdown of OSR1, live cell imaging, microchemotaxis assay, cell volume and ion measurements, immunostaining |
Molecular cancer |
Medium |
24555568
|
| 2014 |
OSR1 downregulates peptide transporters PEPT1 and PEPT2 by decreasing their maximum transport rate and reducing PEPT2 protein abundance at the cell membrane in Xenopus oocytes. The effect requires OSR1 kinase activity (T185E mimics, D164A and T185A are inactive), suggesting kinase-dependent membrane protein regulation. |
Xenopus oocyte electrophysiology, chemiluminescence surface protein assay, constitutively active and kinase-dead mutants |
Kidney & blood pressure research |
Medium |
25531100
|
| 2014 |
Drosophila WNK-Fray (SPAK/OSR1 homolog) signaling cascade regulates K+ flux through Ncc69 (NKCC) in the renal tubule. Fray directly phosphorylates Ncc69 in vitro. A constitutively active Fray mutant rescues the wnk knockdown phenotype, establishing hierarchical WNK→Fray→NKCC signaling for hypotonicity-stimulated K+ flux, demonstrating evolutionary conservation of the WNK-SPAK/OSR1-NKCC cascade. |
Drosophila genetics, in vitro kinase assay, constitutively active mutant rescue, ion flux assay |
The Journal of biological chemistry |
High |
25086033
|
| 2015 |
OSR1 upregulates the intestinal Na+-coupled phosphate cotransporter NaPi-IIb (SLC34A2) in Xenopus oocytes. Constitutively active (T185E)OSR1 and wild-type OSR1 (but not T185A or D164A mutants) significantly increase phosphate-induced currents and maximal transport rate, demonstrating that kinase activity is required. Combined SPAK+OSR1 coexpression shows an additive effect. |
Xenopus oocyte expression, dual electrode voltage clamp, constitutively active and kinase-dead mutants |
Kidney & blood pressure research |
Medium |
26506223
|
| 2016 |
SPAK and OSR1 are essential for K+ homeostasis through their actions on the distal convoluted tubule. SPAK/OSR1 double knockout (DKO) mice develop severe hypokalemia on K+ restriction, unlike single KO mice. DKO mice fail to phosphorylate NCC under K+-restricted conditions, demonstrating that SPAK and OSR1 are redundant but essential effectors of the K+-sensing pathway that maintains plasma K+ through NCC activation. |
SPAK/OSR1 double knockout mice, dietary K+ restriction, plasma K+ measurement, phospho-NCC immunoblotting |
The Journal of physiology |
High |
27068441
|
| 2017 |
Rafoxanide and closantel (antiparasitic agents) inhibit SPAK and OSR1 by binding to a highly conserved allosteric pocket on their C-terminal domains. This allosteric site influences kinase activity and can be exploited for inhibitor design. |
In silico screening, in vitro kinase assay, binding studies |
ChemMedChem |
Medium |
28371477
|
| 2018 |
Verteporfin (photosensitizing clinical agent) inhibits SPAK and OSR1 kinases by binding to their kinase domains in an ATP-independent manner. In cells, verteporfin suppresses phosphorylation of NKCC1, a downstream physiological substrate of SPAK and OSR1. |
In vitro kinase assay, kinase panel screening, cell-based phosphorylation assay |
Chembiochem |
Medium |
29999233
|
| 2019 |
The E3 ubiquitin ligase complex CUL4-DDB1-WDR3/WDR6 binds OSR1 in a phosphorylation-dependent manner via the S-motif (C-terminal serine phosphorylation site). S-motif phosphorylation following osmotic stress disrupts CUL4 complex binding, and OSR1 ubiquitylation is abolished under osmotic stress when its S-motif is phosphorylated, revealing a mechanism linking WNK-dependent S-motif phosphorylation to OSR1 proteostasis. |
Affinity pull-down, mass spectrometry, proteasomal and neddylation inhibitors, immunoblotting |
Chembiochem |
Medium |
31614064
|
| 2019 |
In hypokalemia, WNK4 is the primary active WNK isoform that phosphorylates SPAK/OSR1 within cytoplasmic WNK bodies in the DCT. Phosphorylated SPAK/OSR1 is present both at the apical membrane and in WNK bodies within 12 h of K+ deprivation. In WNK4-deficient mice, larger WNK bodies form containing unphosphorylated WNK1, SPAK, and OSR1. WNK body formation in DCT requires sensing of plasma K+ via the Kir4.1 channel. |
Immunofluorescence microscopy, WNK4-deficient and Kir4.1 knockout mice, dietary K+ manipulation |
American journal of physiology. Renal physiology |
High |
31736353
|
| 2012 |
OSR1 activity is required for LPS-stimulated migration of dendritic cells. In OSR1 knockin (WNK-resistant) dendritic cells, Na+/H+ exchanger activity and ROS production are elevated at baseline, but LPS fails to further increase them or stimulate migration. NKCC1 inhibition with furosemide increases NHE activity to levels similar to OSR1-deficient cells, suggesting OSR1-NKCC1 interaction regulates NHE activity. |
WNK-resistant OSR1 knockin mice, dendritic cell culture, FACS, fluorescent pH indicators, transwell migration assay |
American journal of physiology. Cell physiology |
Medium |
22648948
|
| 2021 |
Pro-resolving FPR2 agonists (WKYMVm and annexin A1) induce phosphorylation of OSR1 at Ser339 via NADPH oxidase-dependent activation of PI3K and PKCδ. Blockade of NADPH oxidase prevents FPR2-induced OSR1(Ser339) phosphorylation, identifying NADPH oxidase→PI3K→OSR1(Ser339) as a pro-resolving signaling axis. |
Pharmacological NADPH oxidase inhibition, CRISPR/Cas9 p22phox knockout cells, phospho-specific immunoblotting |
Antioxidants |
Medium |
33477989
|
| 2022 |
WNK1 HSN2 splice variant regulates neurite outgrowth through OSR1 activation and downstream GSK3β. The HSN2-OSR1/GSK3β signaling axis induces expression of LHX8, a key regulator of cholinergic neural function. HSANII patient-derived HSN2 mutants suppress OSR1 activation, LHX8 induction, and neurite outgrowth, and prevent interaction between wild-type HSN2 and GSK3β. |
Cell-based neurite outgrowth assay, OSR1 activation measurements, co-immunoprecipitation, LHX8 expression analysis, patient mutation analysis |
Scientific reports |
Medium |
36151370
|
| 2005 |
OSR1 was identified through yeast two-hybrid screening as interacting with RELL1 (a RELT family member). OSR1 interacts with all three RELT family members (RELT, RELL1, RELL2) by co-immunoprecipitation and phosphorylates them in an in vitro kinase assay, identifying the RELT family as OSR1 substrates. |
Yeast two-hybrid, co-immunoprecipitation, in vitro kinase assay |
Biochemical and biophysical research communications |
Medium |
16389068
|
| 2012 |
Phosphorylation of NCC by OSR1/SPAK kinases decreases NCC ubiquitination. In mice, low-salt diet decreases NCC ubiquitination while high-salt diet increases it (inversely correlated with phosphorylation and membrane abundance). In COS7 cells, phospho-deficient NCC shows increased ubiquitination while phospho-mimicking NCC shows decreased ubiquitination for both total and surface NCC, establishing that OSR1/SPAK-mediated phosphorylation of NCC protects it from ubiquitin-mediated degradation. |
In vivo mouse models, COS7 cell expression, immunoprecipitation, ubiquitination assay, surface biotinylation |
Biochemical and biophysical research communications |
Medium |
22846565
|
| 2023 |
Disruption of the WNK4-SPAK/OSR1 pathway using a new C57BL/6-specific pT96-NKCC2 antibody reveals that SPAK/OSR1 only mildly affects NKCC2 phosphorylation at baseline; NCC phosphorylation is strongly dependent on this pathway while NKCC2 is not. In WNK4-/- and SPAK/OSR1 double KO mice, pT96-NKCC2 is only slightly or not significantly reduced, suggesting alternative kinases phosphorylate NKCC2. |
New phospho-specific antibody, Wnk4-/-, Osr1-/-, Spak-/-, DKO mice, immunoblotting, furosemide diuresis assay |
American journal of physiology. Renal physiology |
High |
37881876
|